TCL Archive NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed July 9, 1976
TCL Archive Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says September 24, 2010
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests June 5, 1992
TCL Archive Also In This 12-page Issue: NCI To Cut Budgets For New Grants By 29 Percent. R01s To Be Funded At 11th Percentile. February 3, 2006
